Global / Sanofi Genzyme EVP Bill Sibold Reflects on 30 Years of Rare Disease CSR Program
Bill Sibold, Executive Vice President and Head of Sanofi Genzyme, highlights the achievements of the company’s Rare Humanitarian Program over the last 30 years, bringing treatments to patients in developing…